Published in Gene Therapy Weekly, September 28th, 2006
Lipofectamine LTX Reagent effectively delivers DNA into the cell, the first critical step in characterizing gene function, and demonstrates high levels of transfection efficiency and protein expression with more than 90% viability for a wide range of cells, including primary neuronal cells and other...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.